ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
ANXA11 | Annexin A11 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
ANXA2 | Annexin A2 | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
ANXA3 | Annexin A3 | Plasma proteins
| | | | | Expressed in all |
ANXA5 | Annexin A5 | Disease related genes Plasma proteins
| | | | | Expressed in all |
ANXA6 | Annexin A6 | Plasma proteins Transporters
| | | | | Expressed in all |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
AP1S1 | Adaptor-related protein complex 1, sigma 1 subunit | Disease related genes Plasma proteins
| | | | | Expressed in all |
AP2A2 | Adaptor-related protein complex 2, alpha 2 subunit | Plasma proteins
| | | | | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APEH | Acylaminoacyl-peptide hydrolase | Enzymes Plasma proteins
| | | | | Expressed in all |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APOM | Apolipoprotein M | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARCN1 | Archain 1 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins
| | | | | Tissue enhanced |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 | Plasma proteins
| | | | | Expressed in all |
ARPC1A | Actin related protein 2/3 complex, subunit 1A, 41kDa | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ARSB | Arylsulfatase B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ASL | Argininosuccinate lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ASPRV1 | Aspartic peptidase, retroviral-like 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATP2A3 | ATPase, Ca++ transporting, ubiquitous | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |